HKU Scholars Hub: Browsing DSpace

Browsing by Author Locarnini, SA

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 11 of 11

	Title	Author(s)	Issue Date	Views
	Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities Journal:Antiviral Research	Gish, RG Given, BD Lai, CL Locarnini, SA Lau, JYN Lewis, DL Schluep, T	2015	150
	Differential reductions in viral antigens expressed from cccDNAVS integrated DNA in treatment naïve HBeAg positive and negative patients with chronic HBV after RNA interference therapy with ARC-520 Proceeding/Conference:Journal of Hepatology	Yuen, RMF Chan, HLY Liu, K Given, BD Schluep, T Hamilton, J Lai, CL Locarnini, SA Lau, JYN Ferrari, C Gish, RG	2016	106
	Effective inhibition of cccDNA derived mRNA/viral antigens and tolerability with ARC-520 Proceeding/Conference:Hepatology International	Yuen, RMF Chan, HLY Liu, SHK Given, BD Schluep, T Hamilton, J Lai, CL Locarnini, SA Lau, JYN Ferrari, C Gish, RG	2016	83
	Hepatitis B virus infection Journal:Nature Reviews Disease Primers	Yuen, RMF Chen, DS Dusheiko, GM Janssen, HLA Lau, DTY Locarnini, SA Peters, MG Lai, CL	2018	39
	Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region Journal:Hepatology	Stuyver, LJ Locarnini, SA Lok, A Richman, DD Carman, WF Dienstag, JL Schinazi, RF Bartholomeusz, A Di Bisceglie, A De Man, RA Dusheiko, G Furman, PA La Colla, P Lai, CL Lau, JYN Manns, MP Niesters, HGM Omata, M OnoNita, SK Otto, MJ Pillay, D Poynard, T Sommadossi, JP Shouval, D Soriano, V Thomas, H Will, H Zoulim, F	2001	167
	Predicting HBsAg clearance responses during ARC-520 RNA interference (RNAi) therapy based on HBsAg epitope profile analysis Proceeding/Conference:Journal of Hepatology	Walsh, R Yuen, L Hammond, R Deerain, J Given, B Schluep, T Yuen, MF Chan, HLY Lai, CL Hamilton, J Lau, JY Ferrari, C Gish, RG Locarnini, SA	2016	89
	Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen Proceeding/Conference:Journal of Hepatology	Yuen, RMF Liu, SHK Chan, HLY Given, BD Schluep, T Hamilton, J Lai, CL Locarnini, SA Lau, JY Ferrari, C Gish, RG	2017	57
	RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg Journal:Science Translational Medicine	Wooddell, CI Yuen, RMF Chan, HLY Gish, RG Locarnini, SA Chavez, D Ferrari, C Given, BD Hamilton, J Kanner, SB Lai, CL Lai, JYN Schluep, T Xu, Z Lanford, RE Lewis, DL	2017	24
	Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers Journal:Clinical Pharmacology in Drug Development	Schluep, T Lickliter, J Hamilton, J Lewis, DL Lai, CL Lau, JYN Locarnini, SA Gish, RG Given, BD	2017	38
	Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent Journal:Antiviral Research	Gish, RG Yuen, RMF Chan, HLY Given, BD Lai, CL Locarnini, SA Lau, JYN Wooddell, CI Schluep, T Lewis, DL	2015	79
	World Gastroenterology Organisation Global Guideline Hepatitis B Journal:Journal of Clinical Gastroenterology	Feld, J Janssen, HLA Abbas, Z Elewaut, A Ferenci, P Isakov, V Khan, A Lim, SG Locarnini, SA Ono, SK Sollano, J Spearman, CW Yeh, CT Yuen, RMF LeMair, A	2016	39

Showing results 1 to 11 of 11